Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 206.3 Million USD | 4384.78% |
| 2022 | 4.6 Million USD | -72.62% |
| 2021 | 16.8 Million USD | 147.06% |
| 2020 | 6.8 Million USD | -41.38% |
| 2019 | 11.6 Million USD | 252.37% |
| 2018 | 3.29 Million USD | 112.27% |
| 2017 | -26.83 Million USD | 7.09% |
| 2016 | -28.87 Million USD | 60.72% |
| 2015 | -73.52 Million USD | -42.76% |
| 2014 | -51.5 Million USD | -14.51% |
| 2013 | -44.97 Million USD | 13.29% |
| 2012 | -51.86 Million USD | 9.28% |
| 2011 | -57.17 Million USD | 6.52% |
| 2010 | -61.15 Million USD | 23.11% |
| 2009 | -79.54 Million USD | 14.28% |
| 2008 | -92.79 Million USD | -73.31% |
| 2007 | -53.53 Million USD | -48.93% |
| 2006 | -35.95 Million USD | -66.16% |
| 2005 | -21.63 Million USD | -56.54% |
| 2004 | -13.82 Million USD | -15.74% |
| 2003 | -11.94 Million USD | 5.08% |
| 2002 | -12.58 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 51.5 Million USD | -50.15% |
| 2024 Q2 | 188.6 Million USD | 266.21% |
| 2023 FY | 206.3 Million USD | 4384.78% |
| 2023 Q4 | 103.3 Million USD | 99.04% |
| 2023 Q3 | 51.9 Million USD | 90.11% |
| 2023 Q1 | 23.8 Million USD | 40.0% |
| 2023 Q2 | 27.3 Million USD | 14.71% |
| 2022 Q1 | 27.8 Million USD | -4.79% |
| 2022 Q2 | -35 Million USD | -225.9% |
| 2022 Q3 | -5.2 Million USD | 85.14% |
| 2022 Q4 | 17 Million USD | 426.92% |
| 2022 FY | 4.6 Million USD | -72.62% |
| 2021 Q2 | -25 Million USD | -4266.67% |
| 2021 FY | 16.8 Million USD | 147.06% |
| 2021 Q4 | 29.2 Million USD | 131.75% |
| 2021 Q1 | 600 Thousand USD | 103.51% |
| 2021 Q3 | 12.6 Million USD | 150.4% |
| 2020 Q3 | 11.6 Million USD | -19.44% |
| 2020 Q2 | 14.4 Million USD | 785.71% |
| 2020 Q1 | -2.1 Million USD | -142.27% |
| 2020 FY | 6.8 Million USD | -41.38% |
| 2020 Q4 | -17.1 Million USD | -247.41% |
| 2019 FY | 11.6 Million USD | 252.37% |
| 2019 Q1 | 4.4 Million USD | -55.52% |
| 2019 Q2 | 1.4 Million USD | -68.18% |
| 2019 Q3 | 800 Thousand USD | -42.86% |
| 2019 Q4 | 4.96 Million USD | 521.0% |
| 2018 Q1 | -6.56 Million USD | 4.24% |
| 2018 Q2 | -1.69 Million USD | 74.26% |
| 2018 Q3 | 1.65 Million USD | 198.11% |
| 2018 FY | 3.29 Million USD | 112.27% |
| 2018 Q4 | 9.89 Million USD | 496.32% |
| 2017 Q1 | -9.97 Million USD | -9.41% |
| 2017 FY | -26.83 Million USD | 7.09% |
| 2017 Q4 | -6.86 Million USD | -208.04% |
| 2017 Q3 | -2.22 Million USD | 71.33% |
| 2017 Q2 | -7.76 Million USD | 22.15% |
| 2016 Q2 | -4.19 Million USD | 66.36% |
| 2016 Q1 | -12.48 Million USD | 54.33% |
| 2016 Q4 | -9.11 Million USD | -195.98% |
| 2016 FY | -28.87 Million USD | 60.72% |
| 2016 Q3 | -3.08 Million USD | 26.61% |
| 2015 Q3 | -18.92 Million USD | -22.65% |
| 2015 Q1 | -11.83 Million USD | -119.15% |
| 2015 FY | -73.52 Million USD | -42.76% |
| 2015 Q4 | -27.32 Million USD | -44.38% |
| 2015 Q2 | -15.43 Million USD | -30.4% |
| 2014 FY | -51.5 Million USD | -14.51% |
| 2014 Q4 | -5.4 Million USD | 50.21% |
| 2014 Q1 | -6.14 Million USD | -145.76% |
| 2014 Q2 | -29.11 Million USD | -373.81% |
| 2014 Q3 | -10.84 Million USD | 62.75% |
| 2013 Q2 | -10.51 Million USD | 1.37% |
| 2013 FY | -44.97 Million USD | 13.29% |
| 2013 Q4 | -2.5 Million USD | 88.26% |
| 2013 Q3 | -21.29 Million USD | -102.4% |
| 2013 Q1 | -10.66 Million USD | -4.62% |
| 2012 Q4 | -10.19 Million USD | 17.9% |
| 2012 Q1 | -14.78 Million USD | -3.09% |
| 2012 Q3 | -12.41 Million USD | 14.22% |
| 2012 Q2 | -14.47 Million USD | 2.06% |
| 2012 FY | -51.86 Million USD | 9.28% |
| 2011 Q2 | -19.42 Million USD | -97.23% |
| 2011 Q4 | -14.33 Million USD | -5.71% |
| 2011 Q3 | -13.56 Million USD | 30.18% |
| 2011 Q1 | -9.84 Million USD | 52.79% |
| 2011 FY | -57.17 Million USD | 6.52% |
| 2010 Q1 | -13.85 Million USD | 7.21% |
| 2010 Q3 | -12.1 Million USD | 11.75% |
| 2010 Q2 | -13.71 Million USD | 1.04% |
| 2010 Q4 | -20.85 Million USD | -72.38% |
| 2010 FY | -61.15 Million USD | 23.11% |
| 2009 Q4 | -14.93 Million USD | 39.61% |
| 2009 FY | -79.54 Million USD | 14.28% |
| 2009 Q3 | -24.72 Million USD | -22.17% |
| 2009 Q2 | -20.23 Million USD | -3.02% |
| 2009 Q1 | -19.64 Million USD | 30.54% |
| 2008 Q4 | -28.28 Million USD | -36.29% |
| 2008 FY | -92.79 Million USD | -73.31% |
| 2008 Q1 | -19.87 Million USD | -26.84% |
| 2008 Q2 | -23.88 Million USD | -20.17% |
| 2008 Q3 | -20.75 Million USD | 13.11% |
| 2007 Q1 | -11.56 Million USD | -6.25% |
| 2007 Q4 | -15.66 Million USD | -14.88% |
| 2007 FY | -53.53 Million USD | -48.93% |
| 2007 Q3 | -13.63 Million USD | -7.63% |
| 2007 Q2 | -12.67 Million USD | -9.62% |
| 2006 FY | -35.95 Million USD | -66.16% |
| 2006 Q2 | -8.35 Million USD | 0.0% |
| 2006 Q1 | -8.35 Million USD | -28.29% |
| 2006 Q3 | -8.35 Million USD | 0.0% |
| 2006 Q4 | -10.88 Million USD | -30.19% |
| 2005 Q3 | -5.04 Million USD | 0.0% |
| 2005 Q1 | -5.04 Million USD | 0.0% |
| 2005 Q2 | -5.04 Million USD | 0.0% |
| 2005 FY | -21.63 Million USD | -56.54% |
| 2005 Q4 | -6.51 Million USD | -29.22% |
| 2004 FY | -13.82 Million USD | -15.74% |
| 2003 FY | -11.94 Million USD | 5.08% |
| 2002 FY | -12.58 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 434.805% |
| BrainsWay Ltd. | -4.19 Million USD | 5015.416% |
| Cerus Corporation | -37.48 Million USD | 650.295% |
| Envoy Medical, Inc. | -29.9 Million USD | 789.782% |
| electroCore, Inc. | -18.83 Million USD | 1195.359% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 2431.073% |
| IceCure Medical Ltd | -14.65 Million USD | 1507.999% |
| Inogen, Inc. | -102.44 Million USD | 301.368% |
| OrthoPediatrics Corp. | -20.97 Million USD | 1083.599% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 491.714% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 1600.886% |
| MaxCyte, Inc. | -37.92 Million USD | 643.997% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 1839.535% |
| Nexalin Technology, Inc. | -4.64 Million USD | 4537.791% |
| Orthofix Medical Inc. | -151.39 Million USD | 236.266% |
| PAVmed Inc | -64.17 Million USD | 421.465% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 493.2% |
| RxSight, Inc. | -48.6 Million USD | 524.416% |
| Sight Sciences, Inc. | -55.54 Million USD | 471.397% |
| SI-BONE, Inc. | -43.33 Million USD | 576.048% |
| TELA Bio, Inc. | -46.66 Million USD | 542.097% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 516.54% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 1618.81% |
| Acutus Medical, Inc. | -81.66 Million USD | 352.624% |
| Talis Biomedical Corporation | -62 Million USD | 432.704% |
| Spectral AI, Inc. | -20.85 Million USD | 1089.259% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 439.443% |
| CVRx, Inc. | -41.19 Million USD | 600.74% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -32124.506% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 1983.108% |
| Bioventus Inc. | -156.23 Million USD | 232.049% |
| Venus Concept Inc. | -37.25 Million USD | 653.826% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 449.436% |
| LivaNova PLC | 17.54 Million USD | -1075.767% |
| 908 Devices Inc. | -36.39 Million USD | 666.774% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 210.535% |
| Nemaura Medical Inc. | -14.14 Million USD | 1558.596% |
| NeuroPace, Inc. | -32.95 Million USD | 725.986% |
| LENSAR, Inc. | -14.38 Million USD | 1534.332% |
| Apyx Medical Corporation | -18.71 Million USD | 1202.442% |
| Cutera, Inc. | -162.83 Million USD | 226.694% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 2004.894% |
| BioSig Technologies, Inc. | -29.04 Million USD | 810.375% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 349.555% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 1033.949% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | -204.542% |
| Axonics, Inc. | -6.08 Million USD | 3488.633% |
| Outset Medical, Inc. | -172.79 Million USD | 219.389% |
| IRIDEX Corporation | -9.57 Million USD | 2255.695% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 294.812% |
| IRadimed Corporation | 17.19 Million USD | -1099.923% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 2602.426% |
| INVO Bioscience, Inc. | -8.03 Million USD | 2667.641% |
| Telesis Bio, Inc. | -47.72 Million USD | 532.277% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -1914.058% |
| Varex Imaging Corporation | -47.7 Million USD | 532.495% |
| Quipt Home Medical Corp. | -2.78 Million USD | 7510.201% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 1927.928% |
| Pulmonx Corporation | -60.84 Million USD | 439.069% |
| Dynatronics Corporation | -2.69 Million USD | 7747.201% |
| Modular Medical, Inc. | -17.47 Million USD | 1280.882% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 1911.715% |
| Semler Scientific, Inc. | 20.58 Million USD | -902.283% |
| InMode Ltd. | 197.91 Million USD | -4.235% |
| Bruker Corporation | 427.2 Million USD | 51.709% |
| Cytosorbents Corporation | -28.5 Million USD | 823.672% |
| DexCom, Inc. | 541.5 Million USD | 61.902% |
| Align Technology, Inc. | 445.05 Million USD | 53.646% |
| Viveve Medical, Inc. | -22.02 Million USD | 1036.578% |
| ZimVie Inc. | -393.28 Million USD | 152.456% |
| Movano Inc. | -29.28 Million USD | 804.504% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 1798.222% |
| Nexalin Technology, Inc. | -4.64 Million USD | 4537.791% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -32124.506% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 192.673% |
| Profound Medical Corp. | -28.56 Million USD | 822.111% |
| enVVeno Medical Corporation | -23.51 Million USD | 977.275% |
| Surmodics, Inc. | -11.54 Million USD | 1887.385% |
| iCAD, Inc. | -4.84 Million USD | 4356.241% |
| Nuwellis, Inc. | -20.2 Million USD | 1120.832% |
| Biotricity, Inc. | -14.09 Million USD | 1563.714% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 267.172% |
| Aethlon Medical, Inc. | -12.2 Million USD | 1789.851% |
| InspireMD, Inc. | -19.91 Million USD | 1135.851% |
| PAVmed Inc. | -64.17 Million USD | 421.465% |
| BIOLASE, Inc. | -20.63 Million USD | 1099.903% |
| Beyond Air, Inc. | -60.24 Million USD | 442.452% |
| FONAR Corporation | 10.56 Million USD | -1852.231% |
| AxoGen, Inc. | -21.71 Million USD | 1049.991% |
| Vivani Medical, Inc. | -25.65 Million USD | 904.226% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | -623.479% |
| Inari Medical, Inc. | -1.63 Million USD | 12710.024% |
| UFP Technologies, Inc. | 44.92 Million USD | -359.22% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 4119.615% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 3223.293% |
| Tenon Medical, Inc. | -15.58 Million USD | 1424.049% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 1437.353% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 683.876% |
| AdaptHealth Corp. | -678.89 Million USD | 130.388% |
| Sintx Technologies, Inc. | -8.25 Million USD | 2597.881% |
| NanoVibronix, Inc. | -3.71 Million USD | 5659.148% |
| Quanterix Corporation | -32.33 Million USD | 738.028% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 1927.928% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -42436.082% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 167.257% |
| TransMedics Group, Inc. | -25.02 Million USD | 924.277% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 1032.092% |
| NeuroMetrix, Inc. | -6.52 Million USD | 3259.513% |
| Hyperfine, Inc. | -44.23 Million USD | 566.341% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 362.796% |
| Biomerica, Inc. | -5.97 Million USD | 3550.987% |
| Bone Biologics Corporation | -8.94 Million USD | 2405.355% |
| AVITA Medical, Inc. | -39.16 Million USD | 626.703% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 2172.557% |
| Silk Road Medical, Inc | -55.74 Million USD | 470.091% |